Template
Zeige index

Template CDA Device 2005‑09‑07

Id	2.16.840.1.113883.10.12.315 ref ad1bbr-	Gültigkeit ab	2005‑09‑07
Status	Aktiv	Versions-Label
Name	CDADevice	Bezeichnung	CDA Device
Beschreibung	Template CDA Device (Prototyp, direkt abgeleitet aus POCD_RM000040 MIF)
Klassifikation	CDA Entry Level Template
Offen/Geschlossen	Offen (auch andere als die definierten Elemente sind erlaubt)
Benutzt von / Benutzt	Benutzt von 18 Transactions und 304 Templates, Benutzt 0 Templates Benutzt von als Name Version 2.16.840.1.113883.3.1937.777.60.4.5 Transaktion Rune (01) 2023‑07‑04 14:19:29 2.16.840.1.113883.3.1937.99.61.32.4.4 Transaktion Initial 2017‑06‑21 15:05:59 2.16.840.1.113883.3.1937.99.61.26.4.7 Transaktion Base Document 2016‑10‑08 19:37:05 2.16.840.1.113883.2.9.10.1.10.4.3 Transaktion (it-IT) Crea Act 2018‑07‑20 17:01:17 2.16.840.1.113883.3.1937.99.61.5.4.22 Transaktion CDA Document APSR2 2014‑11‑16 11:45:10 2.16.840.1.113883.2.9.77.2.4.3 Transaktion Triage 2017‑03‑02 11:11:11 2.16.840.1.113883.3.1937.777.15.4.8 Transaktion Create Medication Dispense 2019‑02‑17 2.16.840.1.113883.3.1937.777.20.4.2 Transaktion Genetic Testing Report (GTR) (DSTU Release 1) 2018‑03‑22 11:37:04 2.16.756.5.30.1.127.77.2.4.4 Transaktion CDA-CH - StructuredBody Enhanced (2018) 2018‑02‑12 17:54:58 2.16.840.1.113883.3.1937.777.15.4.4 Transaktion Create Medication Statement 2017‑05‑10 2.16.840.1.113883.2.9.10.1.10.4.4 Transaktion (it-IT) Crea Sezione 2018‑07‑20 17:02:38 2.16.840.1.113883.3.1937.777.22.4.20 Transaktion CDA MiBi 2018‑08‑31 08:54:30 1.2.208.184.4.2 Transaktion Initial 2018‑11‑19 22:06:20 2.16.840.1.113883.3.1937.777.15.4.6 Transaktion Create Medication Administration 2019‑02‑17 2.16.840.1.113883.3.1937.777.15.4.2 Transaktion Create Medication Order 2017‑05‑10 2.16.756.5.30.1.127.77.2.4.2 Transaktion CDA-CH - StructuredBody (2020) 2017‑11‑10 09:35:28 2.16.840.1.113883.2.6.60.6.4.2 Transaktion CDA Dokument Strukturierter Pathologiebefund (2.0) 2015‑10‑23 10:32:36 2.16.840.1.113883.2.9.77.2.4.5 Transaktion (it-IT) Dimissioni 2017‑09‑28 12:23:20 1.2.40.0.34.6.0.11.3.139 EXNDS Preis Arzneimittel (1.0.0+20210310) 2020‑10‑06 15:47:15 1.2.208.184.2.10.9 CDA ClinicalDocument (with StructuredBody) 2023‑07‑04 08:28:40 1.2.208.184.10.1.10 DK ClinicalDocument (with StructuredBody) 2021‑08‑30 14:09:05 1.2.208.184.10.1.13 DK Medcom ClinicalDocument (with StructuredBody) (1.5) 2021‑08‑30 14:26:22 1.2.208.184.10.1.43 DK Resume Document Template (1.1) 2023‑07‑04 13:08:22 1.2.208.184.10.1.44 DK Medcom ClinicalDocument (with StructuredBody) (1.5) 2023‑07‑04 13:52:36 1.2.208.184.10.1.45 DK CDA Header (2.0) 2023‑07‑04 13:57:28 1.2.208.184.10.1.46 DK Personal Data Card (3.0) 2023‑08‑08 10:15:04 1.2.208.184.10.2 Care plan Document 2018‑11‑19 21:13:46 1.2.208.184.10.9 Containment PDC DK CDA author 2019‑12‑14 16:27:36 1.2.208.184.10.15 PDC DK CDA Section 2019‑12‑14 17:24:10 1.2.208.184.10.30 Containment APD Participant (Body) 2020‑02‑22 14:56:13 1.2.208.184.10.32 APD CDA Clinical Statement 2020‑06‑21 16:54:06 1.2.208.184.10.33 APD CDA Observation 2020‑06‑21 17:05:15 1.2.208.184.11.1.1 DK CDA ClinicalDocument (with StructuredBody) 2021‑08‑13 10:06:00 1.2.208.184.14.11.2 Appointment CDA Encounter 2019‑12‑15 23:32:24 1.2.208.184.15.1.10.20.1 Health Concern Section 2018‑11‑28 20:54:17 1.2.208.184.15.1.10.20.1.2 Health Concern Sub Section 2018‑11‑19 22:02:34 1.2.208.184.15.1.10.20.2 Goal Section 2018‑11‑28 20:58:20 1.2.208.184.15.1.10.20.2.2 Goal Sub Section 2018‑11‑19 22:19:45 1.2.208.184.15.1.10.20.3 Interventions Section 2018‑11‑28 21:00:20 1.2.208.184.15.1.10.20.3.2 Interventions Sub Section 2018‑11‑19 22:22:11 1.2.208.184.15.1.10.20.4 Outcomes Section 2018‑11‑28 21:01:23 1.2.208.184.15.1.10.20.4.2 Outcomes Sub Section 2018‑11‑19 22:33:18 1.2.208.184.16.1.10.20.1.20 PDC DK Language CDA Observation 2019‑12‑22 11:41:45 1.2.208.184.16.1.10.20.1.21 PDC DK Temporary Address CDA Observation 2019‑12‑22 11:43:31 1.2.208.184.16.1.10.20.1.22 PDC DK Dentist CDA Observation 2019‑12‑22 11:45:33 1.2.208.184.16.1.10.20.1.23 PDC DK Custody CDA Observation 2019‑12‑22 11:22:08 1.2.208.184.16.1.10.20.1.24 PDC DK Contact CDA Observation 2019‑12‑22 11:46:44 1.2.208.184.16.1.10.20.1.25 PDC DK Relative CDA Observation 2019‑12‑22 11:48:03 1.2.208.184.16.1.10.20.1.26 PDC DK Citizen CDA Observation 2019‑12‑22 11:29:00 1.2.208.184.16.1.10.20.1.27 PDC DK Coverage CDA Observation 2019‑12‑22 11:33:55 1.2.208.184.16.1.10.20.1.28 PDC DK Organ CDA Observation 2019‑12‑22 11:35:31 1.2.208.184.16.1.10.20.1.29 PDC DK Treatment Will CDA Observation 2019‑12‑22 11:38:15 1.2.208.184.16.1.10.20.1.30 PDC DK Living Will CDA Observation 2019‑12‑22 11:39:56 1.2.276.0.76.3.1.85.200.77.10.2 Diagnose 2016‑01‑29 12:27:26 1.2.276.0.76.3.1.85.200.77.10.3 Therapie 2016‑01‑29 12:28:19 1.2.276.0.76.3.1.85.200.77.10.4 Wundbeurteilung 2016‑01‑29 12:33:12 1.2.276.0.76.3.1.85.200.77.10.7 psychosoziale Faktoren 2016‑02‑04 15:14:55 1.2.276.0.76.3.1.85.200.77.10.8 individuelle Risikofaktoren 2016‑02‑04 15:24:45 1.2.276.0.76.3.1.85.200.77.10.9 Risikoasssessment 2016‑02‑04 15:28:02 1.2.276.0.76.3.1.85.200.77.10.10 HygieneAssessment 2016‑02‑04 15:30:47 1.2.276.0.76.3.1.85.200.77.10.11 Hautassessment 2016‑02‑04 15:33:52 1.2.276.0.76.3.1.85.200.77.10.12 Details über geheilte Wunden 2016‑02‑04 15:37:09 1.2.276.0.76.3.1.85.200.77.10.13 gesundheitsrelevantes Patientenverhalten 2016‑02‑04 15:45:40 1.2.276.0.76.3.1.85.200.77.10.14 körperliche Beeinträchtigungen 2016‑02‑04 15:48:19 1.2.276.0.76.3.1.85.200.77.10.15 psychosoziale Beeinträchtigungen 2016‑02‑04 15:51:13 1.2.276.0.76.3.1.85.200.77.10.17 relevante med. Daten 2016‑02‑04 16:07:34 1.2.276.0.76.3.1.85.200.77.10.18 Behandlungsziele 2016‑02‑04 16:17:24 1.2.276.0.76.3.1.85.200.77.10.19 Behandlungsplan 2016‑02‑04 16:22:01 1.2.276.0.76.3.1.85.200.77.10.20 benötigte Ausrüstung 2016‑02‑04 16:27:22 1.2.276.0.76.3.1.85.200.77.10.21 Heilungs- und Therapieverlauf 2016‑02‑04 16:32:28 1.2.276.0.76.3.1.85.200.77.10.22 Schmerzmanagement 2016‑02‑04 16:36:00 1.2.276.0.76.3.1.85.200.77.10.23 Hygienemaßnahmen 2016‑02‑04 16:40:10 1.2.276.0.76.3.1.85.200.77.10.24 Wundrandschutz 2016‑02‑04 16:43:46 1.2.276.0.76.3.1.85.200.77.10.25 Kausaltherapie 2016‑02‑04 16:46:11 1.2.276.0.76.3.1.85.200.77.10.26 Patientenedukation 2016‑02‑04 16:49:29 1.2.276.0.76.3.1.85.200.77.10.27 bisherige Ergebnisse 2016‑02‑04 16:54:50 1.2.276.0.76.3.1.85.200.77.10.43 Entlassbericht 2016‑09‑27 18:04:29 1.3.6.1.4.1.19376.1.3.1.6 IHE Laboratory Observation (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015) 2016‑06‑24 13:58:31 1.3.6.1.4.1.19376.1.3.3.2.2 Laboratory Report Item Section (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015) 2016‑06‑24 12:44:54 1.3.6.1.4.1.19376.1.3.10.3.1 Additional Specified Observation Section (2.0) 2016‑11‑13 14:28:08 1.3.6.1.4.1.19376.1.3.10.4.2 UICC/AJCC TNM Staging and Grading Observation (2.0) 2014‑05‑13 15:45:13 1.3.6.1.4.1.19376.1.3.10.4.3 ICD-O-3 Typing and Grading Observation (2.0) 2015‑11‑29 17:03:18 1.3.6.1.4.1.19376.1.3.10.4.4 CDA Supply Container APSR2 (1.0) 2016‑07‑29 1.3.6.1.4.1.19376.1.3.10.4.4 Assessment Scales for Scoring Systems APSR2 (1.9) 2016‑10‑06 12:36:29 1.3.6.1.4.1.19376.1.3.10.4.4 Assessment Scales Observation for Scoring Systems (2.0) 2016‑10‑06 13:12:00 1.3.6.1.4.1.19376.1.3.10.9.26 TNM N-Observation (2.0) 2014‑12‑02 16:34:50 1.3.6.1.4.1.19376.1.3.10.9.27 TNM M-Observation (2.0) 2014‑12‑02 16:32:30 1.3.6.1.4.1.19376.1.3.10.9.33 TNM Serum tumor markers (2.0) 2015‑11‑06 14:28:44 1.3.6.1.4.1.19376.1.3.10.9.37 TNM Number of nodes (2.0) 2014‑12‑02 16:48:36 1.3.6.1.4.1.19376.1.3.10.9.42 Assessment Scoring System APSR 2.0 (2.0) 2016‑10‑10 11:33:36 1.3.6.1.4.1.19376.1.3.10.9.43 Assessment Scoring Item APSR 2.0 (2.0) 2016‑10‑11 10:26:17 1.3.6.1.4.1.19376.1.8.1.1.1 Anatomic Pathology Structured Report Content Module (2.0) 2014‑05‑13 11:57:57 1.3.6.1.4.1.19376.1.8.1.2.1 Clinical Information Section (2.0) 2014‑05‑13 14:38:08 1.3.6.1.4.1.19376.1.8.1.2.2 Intraoperative Observation Section (2.0) 2014‑05‑13 19:29:16 1.3.6.1.4.1.19376.1.8.1.2.3 Macroscopic Observation Section (2.0) 2014‑05‑13 11:57:09 1.3.6.1.4.1.19376.1.8.1.2.4 Microscopic Observation Section (2.0) 2014‑05‑13 14:25:17 1.3.6.1.4.1.19376.1.8.1.2.5 Diagnostic Conclusion Section (2.0) 2014‑05‑13 19:31:26 1.3.6.1.4.1.19376.1.8.1.3.6 Problem Organizer (2.0) 2015‑08‑13 10:24:55 1.3.6.1.4.1.19376.1.8.1.4.7 Containment Additional participant in an entry (2.0) 2016‑07‑12 18:44:06 1.3.6.1.4.1.19376.1.8.1.4.9 AP Observation Entry (2.0) 2014‑05‑14 17:09:54 1.3.6.1.4.1.19376.1.9.1.2.1 IHE Prescription Section Content Module (PRE 2017) 2018‑01‑10 11:13:04 1.3.6.1.4.1.19376.1.9.1.2.2 IHE Pharmaceutical Advice Section Content Moudule (PADV 2017) 2018‑01‑10 11:13:04 1.3.6.1.4.1.19376.1.9.1.2.3 IHE Dispense Section Content Module (DIS 2017) 2018‑01‑10 11:13:04 1.3.6.1.4.1.19376.1.9.1.2.5 IHE Medication List Section Content Module (PML 2017) 2018‑01‑10 08:39:19 1.3.6.1.4.1.19376.1.9.1.2.6 IHE Medication Treatment Plan Section Content Module (2021) 2017‑04‑03 07:47:01 2.16.756.5.30.1.1.10.1.2 EmergencyMedicalServiceProtocol (2017) 2017‑05‑31 17:19:29 2.16.756.5.30.1.1.10.1.9 CDA-CH v2.1 - structuredBody (2020) 2019‑10‑17 15:22:41 2.16.756.5.30.1.1.10.1.14 CDA-CH v2.0 - structuredBody enhanced (2018) 2018‑04‑18 2.16.756.5.30.1.1.10.4.54 Mission Encounter (2017) 2017‑07‑11 09:40:49 2.16.840.1.113883.2.6.60.2.10.3001 NFD Section Allergien, Unverträglichkeiten 2014‑06‑29 13:35:11 2.16.840.1.113883.2.6.60.2.10.3003 NFD Section Implantate 2014‑06‑29 13:40:56 2.16.840.1.113883.2.6.60.2.10.3003 NFD Section Diagnosen 2014‑06‑29 15:31:54 2.16.840.1.113883.2.6.60.2.10.3005 NFD Section Schwangerschaft 2014‑07‑07 14:19:33 2.16.840.1.113883.2.6.60.2.10.3006 NFD Section Risiken Ressourcen 2014‑07‑07 14:32:47 2.16.840.1.113883.2.6.60.2.10.4003 NFD Entry Concern 2014‑07‑02 15:10:03 2.16.840.1.113883.2.6.60.2.10.4003 NFD Entry Concern 2014‑07‑02 23:36:34 2.16.840.1.113883.2.6.60.2.10.4004 NFD Entry Problem 2014‑07‑02 15:11:28 2.16.840.1.113883.2.6.60.2.10.4004 NFD Entry Problem 2014‑07‑02 23:34:57 2.16.840.1.113883.2.6.60.2.10.4004 NFD Entry Problem 2014‑07‑07 15:57:16 2.16.840.1.113883.2.6.60.2.10.4004 NFD Entry Problem 2014‑07‑07 15:57:17 2.16.840.1.113883.2.6.60.2.10.4005 NFD Entry Medikation Verordnung 2014‑07‑02 14:54:43 2.16.840.1.113883.2.6.60.3.10.1 CDA SubstanceAdministration 2016‑04‑22 10:50:09 2.16.840.1.113883.2.6.60.6.10.45 Elston-Ellis-Grading 2016‑05‑24 21:55:39 2.16.840.1.113883.2.6.60.12.10.47 Containment CDA author 2017‑05‑11 14:20:24 2.16.840.1.113883.2.9.10.1.6.21 VPS Sezione Triage 2017‑04‑20 12:01:43 2.16.840.1.113883.2.9.10.1.6.22 Z-Temp VPS Sezione Visita 2017‑04‑20 12:12:06 2.16.840.1.113883.2.9.10.1.6.23 VPS Sezione Decorso Clinico 2017‑04‑20 14:10:52 2.16.840.1.113883.2.9.10.1.6.24 VPS Sezione Dimissione 2017‑04‑20 14:23:41 2.16.840.1.113883.2.9.10.1.6.25 VPS Sezione Richieste 2017‑04‑20 14:25:04 2.16.840.1.113883.2.9.10.1.6.26 VPS Sezione Interventi, Prestazioni, Consulenze e Richieste 2017‑04‑20 14:35:16 2.16.840.1.113883.2.9.10.1.6.27 VPS Sezione Accertamenti 2017‑04‑20 14:44:10 2.16.840.1.113883.2.9.10.1.6.30 VPS Sezione Dati Amministrativi 2017‑04‑20 14:51:06 2.16.840.1.113883.2.9.10.1.6.33 VPS Sezione Allergie 2017‑04‑27 16:39:36 2.16.840.1.113883.2.9.10.1.6.34 VPS Sezione Piano di Cura 2017‑04‑27 17:30:18 2.16.840.1.113883.2.9.10.1.6.43 CDA Observation 2017‑05‑04 18:42:02 2.16.840.1.113883.2.9.10.1.6.45 VPS Organizer Accertamenti 2017‑05‑20 08:07:50 2.16.840.1.113883.2.9.10.1.6.48 Containment CDA Participant (Body) 2017‑05‑20 11:28:30 2.16.840.1.113883.2.9.10.1.6.52 VPS Terapie Farmacologiche (SBADM) 2017‑05‑20 17:09:55 2.16.840.1.113883.2.9.10.1.6.55 VPS Sezione Anamnesi 2017‑05‑22 14:58:22 2.16.840.1.113883.2.9.10.1.6.56 VPS Sezione Inquadramento Iniziale 2017‑05‑22 16:21:59 2.16.840.1.113883.2.9.10.1.6.58 VPS Sezione Esame Obiettivo 2017‑05‑22 16:49:42 2.16.840.1.113883.2.9.10.1.6.59 VPS Sezione Lista Problemi 2017‑05‑22 17:02:11 2.16.840.1.113883.2.9.10.1.6.60 VPS Problem Concern Act 2017‑05‑22 17:18:05 2.16.840.1.113883.2.9.10.1.6.61 VPS Problem Observation 2017‑05‑22 17:34:22 2.16.840.1.113883.2.9.10.1.6.62 VPS Interventi, Prestazioni e Consulenze (Act) 2017‑05‑23 09:24:54 2.16.840.1.113883.2.9.10.1.6.74 VPS Sezione Terapie Farmacologiche alla dimissione 2017‑05‑27 07:59:28 2.16.840.1.113883.2.9.10.1.6.80 Containment CDA Author (Body) 2017‑05‑28 18:36:25 2.16.840.1.113883.2.9.10.1.6.83 VPS Disturbo Riportato Observation 2017‑07‑06 18:06:46 2.16.840.1.113883.2.9.10.1.10.2 Sezione Esenzioni 2018‑05‑21 15:49:16 2.16.840.1.113883.2.9.10.1.10.3 Act Esenzione 2018‑05‑21 15:56:46 2.16.840.1.113883.2.9.77.1.10.900204 Motivo del ricovero 2015‑02‑02 12:56:24 2.16.840.1.113883.2.9.77.1.10.900214 Condizioni e Diagnosi alla dimissione 2015‑02‑02 14:07:35 2.16.840.1.113883.2.9.77.1.10.900238 CDA Observation 2016‑05‑28 22:16:29 2.16.840.1.113883.2.51.10.1.2.1 XeH Header 2021‑06‑30 12:15:42 2.16.840.1.113883.2.51.10.4 XeH Clinical Document (1.0) 2021‑09‑07 16:23:15 2.16.840.1.113883.2.51.10.38 XeH Care Provision Act 2021‑10‑18 16:17:01 2.16.840.1.113883.2.51.10.64 XeH Immunization (1.0) 2022‑05‑06 09:23:08 2.16.840.1.113883.3.51.60.2.0 BC CDA Clinical Document Header 2016‑04‑03 18:54:58 2.16.840.1.113883.3.51.60.3.3 BC CDA StructuredBody 2016‑04‑04 16:51:10 2.16.840.1.113883.3.1818.10.1.2.1 BC CDA ClinicalDocumentGenericEpisodic 2016‑11‑28 15:06:29 2.16.840.1.113883.3.1818.10.1.3.1 BC CDA ClinicalDocumentPatientTransfer 2017‑03‑30 10:51:43 2.16.840.1.113883.3.1818.10.1.4 BC CDA E2E Unstructured Document 2017‑04‑04 15:33:33 2.16.840.1.113883.3.1818.10.3.3 BC Allergy Intolerance Observation Act 2017‑04‑02 06:50:15 2.16.840.1.113883.3.1818.10.3.3 BC Allergy Intolerance Observation Act 2017‑04‑02 08:00:43 2.16.840.1.113883.3.1818.10.3.3 BC Allergy Intolerance Observation Act 2017‑04‑02 08:08:32 2.16.840.1.113883.3.1818.10.3.9 BC Encounter Event 2017‑04‑02 22:14:30 2.16.840.1.113883.3.1818.10.4.7 BC Medication Dispense Event 2017‑04‑01 05:18:24 2.16.840.1.113883.3.1818.10.4.19 Containment BC Provider Participant (Body) 2017‑04‑01 20:00:38 2.16.840.1.113883.3.1818.10.4.20 BC Medication Prescription Event 2017‑04‑01 06:19:37 2.16.840.1.113883.3.1818.10.4.24 BC Reason Observation 2017‑04‑01 05:57:31 2.16.840.1.113883.3.1818.10.4.30 BC Severity Observation 2017‑04‑01 22:54:28 2.16.840.1.113883.3.1818.10.4.37 BC Order Indicator 2017‑04‑01 05:39:26 2.16.840.1.113883.3.1818.10.4.38 BC Record ID Link 2017‑04‑01 05:48:33 2.16.840.1.113883.3.1818.10.7.1 BC CDA E2E Clinical Document Header 2017‑03‑31 00:20:01 2.16.840.1.113883.3.1937.99.60.7.10.4.1 Immunization 2017‑03‑08 2.16.840.1.113883.3.1937.99.61.5.10.900216 CDA Observation 2013‑12‑04 10:55:24 2.16.840.1.113883.3.1937.99.61.5.10.900239 eLab_Specimen Received_ 2014‑01‑14 14:12:16 2.16.840.1.113883.3.1937.99.61.5.10.900240 eLab_Specimen Received_ 2014‑01‑14 14:12:39 2.16.840.1.113883.3.1937.99.61.5.10.900241 eLab_Specimen Received_ 2014‑01‑14 14:13:27 2.16.840.1.113883.3.1937.99.61.5.10.900242 eLab_Specimen Received_ 2014‑01‑14 14:13:28 2.16.840.1.113883.3.1937.99.61.5.10.900243 eLab_Specimen Received_ 2014‑01‑14 14:13:28 2.16.840.1.113883.3.1937.99.61.5.10.900244 eLab_Specimen Received_ 2014‑01‑14 14:13:29 2.16.840.1.113883.3.1937.99.61.5.10.900245 eLab_Specimen Received_ 2014‑01‑14 14:13:29 2.16.840.1.113883.3.1937.99.61.5.10.900246 eLab_Specimen Received_ 2014‑01‑14 14:13:29 2.16.840.1.113883.3.1937.99.61.5.10.900247 eLab_Specimen Received_ 2014‑01‑14 14:13:30 2.16.840.1.113883.3.1937.99.61.5.10.900265 CDA Organizer 2014‑01‑14 14:17:08 2.16.840.1.113883.3.1937.99.61.5.10.900273 Anatomic Pathology Structured Report 2014‑05‑13 11:57:57 2.16.840.1.113883.3.1937.99.61.5.10.900275 APSR2 Clinical Information Section 2014‑05‑13 14:38:08 2.16.840.1.113883.3.1937.99.61.5.10.900276 TNM Observation 2014‑05‑13 15:45:13 2.16.840.1.113883.3.1937.99.61.5.10.900277 APSR2 Intraoperative Observation Section 2014‑05‑13 19:29:16 2.16.840.1.113883.3.1937.99.61.5.10.900278 APSR2 Diagnostic Conclusion Section 2014‑05‑13 19:31:26 2.16.840.1.113883.3.1937.99.61.5.10.900280 APSR2 AP Observation Entry 2014‑05‑14 17:09:54 2.16.840.1.113883.3.1937.99.61.5.10.900283 APSR2 Specimen procedure step Entry 2014‑07‑29 16:02:02 2.16.840.1.113883.3.1937.99.61.5.10.900286 einheitlicher onkologischer Basisdatensatz 2014‑12‑01 15:14:45 2.16.840.1.113883.3.1937.99.61.5.10.900290 ADT-Tod 2014‑12‑02 09:05:37 2.16.840.1.113883.3.1937.99.61.5.10.900293 ADT Tod 2014‑12‑02 11:02:38 2.16.840.1.113883.3.1937.99.61.5.10.900296 TNM M-Observation 2014‑12‑02 16:32:30 2.16.840.1.113883.3.1937.99.61.5.10.900304 APSR2 Specimen Organizer 2014‑12‑22 17:58:40 2.16.840.1.113883.3.1937.99.61.5.10.900305 IHE Electrophysiology Implant/Explant Report Content (EPRC-IE) 2015‑03‑03 16:17:56 2.16.840.1.113883.3.1937.99.61.5.10.900311 CDA SubstanceAdministration 2018‑08‑02 12:16:53 2.16.840.1.113883.3.1937.99.61.5.10.900312 CDA SubstanceAdministration 2018‑08‑02 12:18:33 2.16.840.1.113883.3.1937.99.61.15.10.900202 Andrew CDA Test Document (1.0) 2015‑02‑13 20:52:59 2.16.840.1.113883.3.1937.99.61.15.10.900205 pCSCDAHeader (2015-01-30) 2015‑03‑18 14:57:09 2.16.840.1.113883.3.1937.99.61.15.10.900205 pCSCDAHeader (2015-03-19) 2015‑03‑19 16:46:00 2.16.840.1.113883.3.1937.99.61.15.10.900205 pCSCDAHeader (2015-04-28) 2015‑04‑28 23:29:35 2.16.840.1.113883.3.1937.99.61.15.10.900208 Canada CDA Header (20150429) 2015‑04‑29 22:30:07 2.16.840.1.113883.3.1937.99.61.16.10.9 CDA ClinicalDocumentTesti 2019‑05‑16 11:00:30 2.16.840.1.113883.3.1937.99.61.16.10.10 CDA ClinicalDocumentMikaTesti 2019‑05‑16 11:05:40 2.16.840.1.113883.3.1937.99.61.17.10.1 Heart Failure ClinicalDocument 2015‑05‑09 10:51:13 2.16.840.1.113883.3.1937.99.61.19.10.24 CDA Observation1 2017‑08‑10 15:15:49 2.16.840.1.113883.3.1937.99.61.19.10.71 Ambulanzbefund 2019‑05‑10 08:58:00 2.16.840.1.113883.3.1937.99.61.19.10.78 TEST_AKL_Ambulanzbefund (2020) 2020‑02‑05 15:44:24 2.16.840.1.113883.3.1937.99.61.19.10.78 TEST_AKL_Ambulanzbefund (2020.1) 2020‑11‑25 10:42:33 2.16.840.1.113883.3.1937.99.61.21.10.2 BC trial template ClinicalDocument nonXMLbody 2016‑10‑21 19:38:13 2.16.840.1.113883.3.1937.99.61.21.10.23 Pan-Canadian Header Practice (0.01) 2019‑09‑11 01:40:57 2.16.840.1.113883.3.1937.99.61.21.10.47 NH v2 to CDA Mapping 2019‑09‑17 01:12:11 2.16.840.1.113883.3.1937.99.61.21.10.51 BC CDA MedicalImaging 2020‑06‑13 00:18:42 2.16.840.1.113883.3.1937.99.61.21.10.75 Radiology Comparison Study - Observation 2020‑08‑11 20:29:30 2.16.840.1.113883.3.1937.99.61.26.10.46 CDA ClinicalDocument 2017‑03‑08 00:38:01 2.16.840.1.113883.3.1937.99.61.27.10.3 tsc_test_CDASection 2016‑05‑27 11:53:53 2.16.840.1.113883.3.1937.99.61.27.10.4 Laboratory Specialty Text and Entry (LAB TF-3, Revision 6.0 - Final Text, July 14, 2015) 2016‑06‑24 12:40:20 2.16.840.1.113883.3.1937.99.61.27.10.5 Containment test_tsc_Participant 2016‑07‑02 13:07:00 2.16.840.1.113883.3.1937.99.61.27.10.8 Containment CDA Participant (Body) 2016‑07‑16 07:37:41 2.16.840.1.113883.3.1937.99.61.27.10.11 CDA Observation 2018‑11‑13 14:00:31 2.16.840.1.113883.3.1937.99.61.27.10.12 JBl_CDA Observation (JBL-V1) 2018‑11‑13 14:14:08 2.16.840.1.113883.3.1937.99.61.27.10.13 NewTemplate (V0) 2018‑11‑13 14:14:16 2.16.840.1.113883.3.1937.99.61.27.10.14 JBl_CDA Observation (JBL-V1) 2018‑11‑13 14:14:49 2.16.840.1.113883.3.1937.99.61.27.10.15 PGRNewTemplateTest (V0) 2018‑11‑13 14:17:21 2.16.840.1.113883.3.1937.99.61.27.10.16 NewTemplate (V0) 2018‑11‑13 14:17:38 2.16.840.1.113883.3.1937.99.61.27.10.17 CDA ClinicalDocument (with StructuredBody) 2019‑08‑22 09:46:40 2.16.840.1.113883.3.1937.99.61.27.10.18 CDA ClinicalDocument (with StructuredBody) 2019‑08‑22 09:46:48 2.16.840.1.113883.3.1937.99.61.27.10.19 FLM_SupplyOneRelationShipSubstanceAdministration (2019) 2019‑08‑29 14:54:39 2.16.840.1.113883.3.1937.99.61.27.10.20 FLM_SubstanceAdministration 2019‑08‑29 15:03:30 2.16.840.1.113883.3.1937.99.61.27.10.21 FLM_Supply 2019‑08‑29 15:51:42 2.16.840.1.113883.3.1937.99.61.27.10.22 FLM_SubstanceAdministration2 2019‑09‑01 21:32:53 2.16.840.1.113883.3.1937.99.61.27.10.23 FLM_SupplyTwoRelationShipToSubstanceAdministration 2019‑09‑01 21:33:57 2.16.840.1.113883.3.1937.99.61.28.10.4 CDA Nivel 1 (1) 2017‑04‑22 23:33:51 2.16.840.1.113883.3.1937.99.61.28.10.5 Header CDA Minimo (1) 2017‑09‑03 16:34:55 2.16.840.1.113883.3.1937.99.61.30.10.59 _Immunization (harmonization) 2021‑06‑23 19:42:25 2.16.840.1.113883.3.1937.99.61.30.10.64 Prescrizione specialistica (with StructuredBody) (1.0) 2022‑06‑13 15:50:01 2.16.840.1.113883.3.1937.99.61.30.10.65 Prescrizione farmaceutica (with StructuredBody) (1.0) 2022‑06‑13 17:14:33 2.16.840.1.113883.3.1937.99.61.30.10.68 Containment CDA2 author 2022‑06‑14 12:05:30 2.16.840.1.113883.3.1937.99.61.31.10.1.2 My Section 2014‑02‑08 16:16:07 2.16.840.1.113883.3.1937.99.61.32.10.23 CDA ClinicalDocument (with StructuredBody) 2017‑06‑21 14:48:45 2.16.840.1.113883.3.1937.99.61.38.10.19 Darreichungsform 2018‑02‑06 09:41:53 2.16.840.1.113883.3.1937.99.61.38.10.20 Arzneimittel 2018‑02‑06 09:45:28 2.16.840.1.113883.3.1937.99.61.45.10.4 CDA ClinicalDocument T 2018‑04‑16 10:35:28 2.16.840.1.113883.3.1937.99.61.45.10.5 CDA Section t 2018‑04‑16 11:44:27 2.16.840.1.113883.3.1937.99.61.45.10.6 CDA Observation t 2018‑04‑16 12:13:51 2.16.840.1.113883.3.1937.99.61.45.10.16 Adipositas Studie 2018‑04‑24 10:33:11 2.16.840.1.113883.3.1937.99.61.45.10.17 CDA Adipositas Studie 2018‑04‑24 10:41:37 2.16.840.1.113883.3.1937.99.61.45.10.37 Dok3 Sonstiges 2018‑05‑02 17:52:41 2.16.840.1.113883.3.1937.99.61.45.10.39 Dok3 kleines Blutbild ? 2018‑05‑02 17:58:11 2.16.840.1.113883.3.1937.99.61.45.10.50 ASIC weitere Vitaldaten 2018‑05‑08 16:29:04 2.16.840.1.113883.3.1937.99.61.45.10.62 CDA Observation 2018‑08‑28 13:22:11 2.16.840.1.113883.3.1937.99.61.66.10.1 CDA ClinicalDocument 2020‑07‑31 11:03:27 2.16.840.1.113883.3.1937.99.61.66.10.2 CDA ClinicalDocument (GReg) 2020‑07‑31 16:48:37 2.16.840.1.113883.3.1937.99.61.67.10.17 CDA ClinicalDocument 2020‑12‑09 11:44:45 2.16.840.1.113883.3.1937.99.61.67.10.18 XeH Clinical Document 2020‑12‑09 11:45:40 2.16.840.1.113883.3.1937.777.17.10.1 Containment BC CDA Author (Body) 2017‑03‑29 17:54:30 2.16.840.1.113883.3.1937.777.17.10.36 BC CDA E2E EMR Conversion 2017‑04‑02 07:42:02 2.16.840.1.113883.3.1937.777.17.10.47 BC CDA Organizer 2017‑04‑02 19:50:56 2.16.840.1.113883.3.1937.777.17.10.48 BC Clinically Measured Observations Organizer 2017‑04‑02 19:58:41 2.16.840.1.113883.3.1937.777.17.10.50 BC CDA Organizer 2017‑04‑02 20:15:06 2.16.840.1.113883.3.1937.777.21.10.6 CDA Observation 2018‑07‑30 14:20:18 2.16.840.1.113883.3.1937.777.22.10.1 CDA ClinicalDocument 2018‑08‑31 08:59:16 2.16.840.1.113883.3.1937.777.24.10.39 Containment CDA Author (Body) 2019‑03‑12 16:40:53 2.16.840.1.113883.3.1937.777.26.10.1 Konsilanfrage 2018‑07‑20 11:22:22 2.16.840.1.113883.3.1937.777.29.10.1 CDA ClinicalDocument (with StructuredBody) 2019‑05‑02 16:51:55 2.16.840.1.113883.3.1937.777.35.10.9 Elektronischer Impfpass ActVaccination (draft) 2019‑05‑20 17:08:53 2.16.840.1.113883.3.1937.777.35.10.65 Rejected Vaccination (0) 2019‑05‑24 21:00:39 2.16.840.1.113883.3.1937.777.35.10.68 Diagnose (cdaab2) 2019‑05‑24 22:58:02 2.16.840.1.113883.3.1937.777.60.10.1 DK Resume Document Template (1.0) 2021‑08‑09 13:04:11 2.16.840.1.113883.3.1937.777.60.10.3 DK Resume Section 2021‑08‑09 13:15:46 2.16.840.1.113883.3.1937.777.60.10.4 CDA ClinicalDocument 2021‑08‑09 13:22:04 2.16.840.1.113883.3.1937.777.78.10.8 CDA Observation 2024‑01‑26 11:33:16 2.16.840.1.113883.10.12.1 CDA ClinicalDocument 2005‑09‑07 2.16.840.1.113883.10.12.2 CDA ClinicalDocument (with StructuredBody) 2005‑09‑07 2.16.840.1.113883.10.12.3 CDA ClinicalDocument (with nonXMLBody) 2005‑09‑07 2.16.840.1.113883.10.12.102 Containment CDA author 2005‑09‑07 2.16.840.1.113883.10.12.112 CDA component 2005‑09‑07 2.16.840.1.113883.10.12.201 CDA Section 2005‑09‑07 2.16.840.1.113883.10.12.202 CDA StructuredBody 2005‑09‑07 2.16.840.1.113883.10.12.300 CDA Clinical Statement 2005‑09‑07 2.16.840.1.113883.10.12.301 CDA Act 2005‑09‑07 2.16.840.1.113883.10.12.302 CDA Encounter 2005‑09‑07 2.16.840.1.113883.10.12.303 CDA Observation 2005‑09‑07 2.16.840.1.113883.10.12.304 CDA ObservationMedia 2005‑09‑07 2.16.840.1.113883.10.12.305 CDA Organizer 2005‑09‑07 2.16.840.1.113883.10.12.306 CDA Procedure 2005‑09‑07 2.16.840.1.113883.10.12.307 CDA RegionOfInterest 2005‑09‑07 2.16.840.1.113883.10.12.308 CDA SubstanceAdministration 2005‑09‑07 2.16.840.1.113883.10.12.309 CDA Supply 2005‑09‑07 2.16.840.1.113883.10.12.318 Containment CDA Author (Body) 2005‑09‑07 2.16.840.1.113883.10.12.321 Containment CDA Participant (Body) 2005‑09‑07 2.16.840.1.113883.10.20.20 Genetic Testing Report 2013‑02‑01 2.16.840.1.113883.10.21.4.1 UV Medication Order (STU1) 2015‑10‑07 2.16.840.1.113883.10.21.4.1 UV Medication Order (R1-STU2-ballot) 2021‑08‑04 17:03:38 2.16.840.1.113883.10.21.4.1 UV Medication Order (2023) 2023‑01‑30 08:30:30 2.16.840.1.113883.10.21.4.1 UV Medication Order (2023) 2023‑01‑31 10:52:39 2.16.840.1.113883.10.21.4.1 UV Medication Order (2023) 2023‑01‑31 11:29:28 2.16.840.1.113883.10.21.4.2 UV Dispense Request (R1-STU2-ballot) 2016‑05‑01 2.16.840.1.113883.10.21.4.3 UV ClinicalStatement Observation (R1-STU2-ballot) 2016‑05‑01 2.16.840.1.113883.10.21.4.7 UV Medication Statement (STU1) 2017‑05‑01 2.16.840.1.113883.10.21.4.7 UV Medication Statement (R1-STU2-ballot) 2021‑08‑04 14:09:15 2.16.840.1.113883.10.21.4.7 UV Medication Statement (2023) 2023‑01‑30 08:32:34 2.16.840.1.113883.10.21.4.8 UV Medication Order Reference (R1-STU2-ballot) 2017‑03‑30 2.16.840.1.113883.10.21.4.12 UV Comment Activity (R1-STU2-ballot) 2018‑03‑21 2.16.840.1.113883.10.21.4.13 UV Medication Administration (R1-STU2-ballot) 2019‑02‑17 2.16.840.1.113883.10.21.4.13 UV Medication Administration (2023) 2023‑01‑30 08:31:37 2.16.840.1.113883.10.21.4.15 UV Medication Dispense (STU1) 2019‑02‑17 2.16.840.1.113883.10.21.4.15 UV Medication Dispense (R1-STU2-ballot) 2021‑08‑04 16:35:09 2.16.840.1.113883.10.21.4.15 UV Medication Dispense (2023) 2023‑01‑30 08:28:25 2.16.840.1.113883.10.21.4.15 UV Medication Dispense (2023) 2023‑01‑30 08:33:47 2.16.840.1.113883.10.22.4.15 IPS Immunization (STU1) 2017‑03‑08 2.16.840.1.113883.10.22.4.23 IPS ObservationMedia (STU1) 2017‑04‑06 2.16.840.1.113883.10.22.4.23 IPS ObservationMedia (2021) 2021‑09‑02 12:02:16 2.16.840.1.113883.10.22.4.39 IPS Planned Act (TI-2020) 2020‑05‑08 18:08:52 2.16.840.1.113883.10.22.4.39 IPS Planned Act (2022) 2022‑07‑15 13:55:11 2.16.840.1.113883.10.22.4.47 IPS Planned Immunization (TI-2020) 2020‑05‑08 17:29:18 2.999.1.1 tsc_test1_Obs1 (derived from CDA Observation) 2016‑07‑01 16:24:10 2.999.2.1 tsc_test1_Obs2 (derived from tsc_test1_Obs1) 2016‑07‑01 16:44:35
Alles ausklappenAlles einklappen Item DT Kard Konf Beschreibung Label @classCode cs 0 … 1 F DEV @determinerCode cs 0 … 1 F INSTANCE hl7:code CE 0 … 1 CDADevice   CONF Der Wert von @code muss gewählt werden aus dem Value Set 2.16.840.1.113883.1.11.16040 EntityCode (DYNAMIC) hl7:manufacturerModelName SC 0 … 1 CDADevice hl7:softwareName SC 0 … 1 CDADevice